Welcome to HitGen


做最具创新力的生物医药企业     用最先进的科学技术赋能创新药研发

  1. 关于我们
  2. 发表文章

Selecting Approaches for Hit Identification and Increasing Options by Building the Efficient Discovery of Actionable Chemical Matter from DNA-Encoded Libraries 发布时间:2021-01-08


Over the past 20 years, the toolbox for discovering small-molecule therapeutic starting points has expanded considerably. Pharmaceutical researchers can now choose from technologies that, in addition to traditional high-throughput knowledge-based and diversity screening, now include the screening of fragment and fragment-like libraries, affinity selection mass spectrometry, and selection against DNA-encoded libraries (DELs). Each of these techniques has its own unique combination of advantages and limitations that makes them more, or less, suitable for different target classes or discovery objectives, such as desired mechanism of action. Layered on top of this are the constraints of the drug-hunters themselves, including budgets, timelines, and available platform capacity; each of these can play a part in dictating the hit identification strategy for a discovery program. In this article, we discuss some of the factors that we use to govern our building of a hit identification roadmap for a program and describe the increasing role that DELs are playing in our discovery strategy. Furthermore, we share our learning during our initial exploration of DEL and highlight the approaches we have evolved to maximize the value returned from DEL selections. Topics addressed include the optimization of library design and production, reagent validation, data analysis, and hit confirmation. We describe how our thinking in these areas has led us to build a DEL platform that has begun to deliver tractable matter to our global discovery portfolio.

DISCOVERY: Advancing the Science of Drug Discovery, vol. 26, no. 2, Feb. 2021, pp. 263–280


Link: https://journals.sagepub.com/doi/full/10.1177/2472555220979589



为了使您在浏览本网站时获得最佳的体验,您需同意我们对Cookies的使用。想要了解更多有关于Cookies的信息,请阅读我们的 隐私政策。